EJP PHARMACEUTICAL ApS: Financial statements 2022
CVR: 87923614
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -49,225 and a net result of DKK -477,660 compared with DKK 442,551 the year before. Equity in the 2022 report amounted to DKK 6,683,130. The solvency ratio was 98.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -49,225
- Profit/Loss
- DKK -477,660
- Equity
- DKK 6,683,130
- Total Assets
- DKK 6,764,642
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -49 t. | -478 t. | 6.7 mio. | 1 |
| 2021 | - | -40 t. | 443 t. | 7.3 mio. | 1 |
| 2020 | - | -75 t. | -140 t. | 6.9 mio. | 1 |
| 2019 | - | - | 566 t. | 7.6 mio. | 1 |
| 2018 | - | - | -685 t. | 7.1 mio. | 1 |
Keep an eye on EJP PHARMACEUTICAL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
EJP PHARMACEUTICAL ApS has published its annual report for 2021. Gross profit came to DKK -39,771, and the net result was DKK 442,551.
About EJP PHARMACEUTICAL ApS
EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity in the 2025 report amounted to DKK 814,282.